![]()
11.04.20162310
The US Food and Drug Administration (FDA) has issued a new alert about the potential for increased risk for heart failure in patients taking the type 2 diabetes drugs saxagliptin (Onglyza, AstraZeneca Pharmaceuticals LP) and alogliptin (Nesina, Takeda Pharmaceuticals).
![]()
08.04.20162073
What are the risks and benefits in atrial fibrillation (AF) patients with previous intracranial hemorrhage (ICH) treated with warfarin, compared to antiplatelet or no antithrombotic therapies?
![]()
07.04.20162258
What is the safety and efficacy of prolonged dual antiplatelet therapy (DAPT) in patients with diabetes?
![]()
06.04.20162570
Global Educational Forum “Russian Cardiovascular Days” 2016 21-23 April, Saint-Petersburg.
![]()
06.04.20162358
Is earlier outpatient follow-up after acute myocardial infarction (AMI) associated with higher rates of medication adherence?
![]()
05.04.20162303
Both rate and rhythm control strategies are safe and effective for patients in atrial fibrillation after cardiac surgery, according to data presented at the American College of Cardiology Scientific Session.
![]()
04.04.20161926
Is there an association between elevated triglycerides and long-term all-cause mortality among patients with established coronary heart disease (CHD)?
